BR9915512A - Análogos antagonìsticos de gh-rh que inibem igf-i e -ii - Google Patents

Análogos antagonìsticos de gh-rh que inibem igf-i e -ii

Info

Publication number
BR9915512A
BR9915512A BR9915512-5A BR9915512A BR9915512A BR 9915512 A BR9915512 A BR 9915512A BR 9915512 A BR9915512 A BR 9915512A BR 9915512 A BR9915512 A BR 9915512A
Authority
BR
Brazil
Prior art keywords
analogs
inhibit igf
inhibit
antagonistic
antagonistic analogs
Prior art date
Application number
BR9915512-5A
Other languages
English (en)
Inventor
Andrew V Schally
Jozsef Varga
Marta Zarandi
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tulane filed Critical Univ Tulane
Publication of BR9915512A publication Critical patent/BR9915512A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"ANáLOGOS ANTAGONìSTICOS DE GH-RH QUE INIBEM IGF-I E -II" é proporcionada uma nova série de análogos sintéticos de hGH-RH (1-29)NH~ 2~. Estes análogos inibem a atividade de hGH-RH endógeno, e portanto impedem a liberação do hormónio do crescimento. As potências inibitórias mais fortes dos novos análogos, em comparação com as previamente descritas, resultam da substituição de diversos aminoácidos.
BR9915512-5A 1998-11-25 1999-11-23 Análogos antagonìsticos de gh-rh que inibem igf-i e -ii BR9915512A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/199,381 US6057422A (en) 1998-11-25 1998-11-25 Antagonistic analogs of GH-RH inhibiting IGF-I and -II
PCT/US1999/027822 WO2000031136A1 (en) 1998-11-25 1999-11-23 Antagonistic analogs of gh-rh inhibiting igf-i and -ii

Publications (1)

Publication Number Publication Date
BR9915512A true BR9915512A (pt) 2001-08-07

Family

ID=22737273

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9915512-5A BR9915512A (pt) 1998-11-25 1999-11-23 Análogos antagonìsticos de gh-rh que inibem igf-i e -ii

Country Status (29)

Country Link
US (2) US6057422A (pt)
EP (1) EP1133522B1 (pt)
JP (1) JP2002530432A (pt)
KR (1) KR100629013B1 (pt)
CN (1) CN100422211C (pt)
AR (1) AR022392A1 (pt)
AT (1) ATE332310T1 (pt)
AU (1) AU757222B2 (pt)
BG (1) BG65137B1 (pt)
BR (1) BR9915512A (pt)
CA (1) CA2351665C (pt)
CO (1) CO5180565A1 (pt)
CZ (1) CZ20011794A3 (pt)
DE (1) DE69932255T2 (pt)
DK (1) DK1133522T3 (pt)
ES (1) ES2264279T3 (pt)
HK (1) HK1036461A1 (pt)
HU (1) HUP0105094A3 (pt)
IL (1) IL142899A0 (pt)
NO (1) NO20012489L (pt)
NZ (1) NZ511307A (pt)
PL (1) PL197471B1 (pt)
PT (1) PT1133522E (pt)
RU (1) RU2235099C2 (pt)
SK (1) SK7252001A3 (pt)
TR (1) TR200101492T2 (pt)
TW (1) TW585873B (pt)
UA (1) UA68407C2 (pt)
WO (1) WO2000031136A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003006611A2 (en) * 2001-07-12 2003-01-23 Exelixis, Inc. GPCs AS MODIFIERS OF THE IRRTK AND p21 PATHWAYS AND METHODS OF USE
US20040121407A1 (en) * 2002-09-06 2004-06-24 Elixir Pharmaceuticals, Inc. Regulation of the growth hormone/IGF-1 axis
RU2005111253A (ru) * 2002-09-18 2005-11-20 Сантр Оспиталье Де Л` Юниверсите Де Монреаль (Схюм) (Ca) Аналоги ghrh
TW200517400A (en) * 2003-08-05 2005-06-01 Univ Tulane Antagonistic analogs of GH-RH (2003)
BRPI0910873A2 (pt) * 2008-03-28 2015-10-06 Us Of America Represented By The Dept Of Veterans Affairs análogos antagonistas de gh-rh substituídos nos terminais n e c
US8691942B2 (en) 2008-03-28 2014-04-08 University Of Miami N- and C- terminal substituted antagonistic analogs of GH-RH
EP2719392B1 (en) 2008-06-12 2019-07-24 Ipsen Bioinnovation Limited Fusion proteins for use in the treatment of acromegaly
US10240138B2 (en) 2008-06-12 2019-03-26 Ipsen Bioinnovation Limited Polypeptides that bind to and inhibit secretion from growth hormone secreting cells
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
US8227421B2 (en) * 2009-09-17 2012-07-24 University Of Miami Fluorinated GHRH antagonists
CN103547591A (zh) 2011-04-21 2014-01-29 瑟瑞技术公司 生长激素释放因子(grf)类似物及其用途
US9079974B2 (en) * 2011-12-21 2015-07-14 The University Of Miami GH-RH analogs with potent agonistic effects
EP2934565B1 (en) 2012-12-21 2019-03-13 University of Miami Ghrh agonists for the treatment of ischemic disorders
WO2014100816A2 (en) 2012-12-21 2014-06-26 University Of Miami Ghrh agonists for islet cell transplantation and function and the treatment of diabetes
EP3218395B1 (en) 2014-11-12 2022-01-05 The United States of America, as represented by The Secretary, Department of Health and Human Services Treatment of hormonal disorders of growth
CA3129405A1 (en) 2019-02-08 2020-08-13 United States Government As Represented By The Department Of Veterans Affairs Growth hormone-releasing hormone antagonists and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659693A (en) * 1984-04-30 1987-04-21 Syntex (U.S.A.) Inc. N,N'-dialkyl substituted guanidino amino acyl residue substituted GRF-analog peptides
CA2082059A1 (en) * 1990-05-04 1991-11-05 David H. Coy Synthetic grf analogs
US5550212A (en) * 1993-12-17 1996-08-27 The Administrators Of The Tulane Educational Fund Analogues of hGH-RH(1-29)NH2 having antagonistic activity
US5942489A (en) * 1996-05-03 1999-08-24 The Administrators Of The Tulane Educational Fund HGH-RH(1-29)NH2 analogues having antagonistic activity

Also Published As

Publication number Publication date
CZ20011794A3 (cs) 2002-02-13
KR100629013B1 (ko) 2006-09-26
US6057422A (en) 2000-05-02
HUP0105094A2 (hu) 2002-04-29
CN100422211C (zh) 2008-10-01
DE69932255D1 (de) 2006-08-17
EP1133522B1 (en) 2006-07-05
DK1133522T3 (da) 2006-11-06
SK7252001A3 (en) 2002-02-05
IL142899A0 (en) 2002-04-21
TW585873B (en) 2004-05-01
BG65137B1 (bg) 2007-03-30
PL197471B1 (pl) 2008-04-30
CA2351665C (en) 2008-09-02
NO20012489L (no) 2001-07-04
KR20010101079A (ko) 2001-11-14
AU2029100A (en) 2000-06-13
WO2000031136A1 (en) 2000-06-02
BG105638A (en) 2002-01-31
ES2264279T3 (es) 2006-12-16
ATE332310T1 (de) 2006-07-15
DE69932255T2 (de) 2007-05-31
NZ511307A (en) 2005-01-28
HK1036461A1 (en) 2002-01-04
RU2235099C2 (ru) 2004-08-27
WO2000031136A9 (en) 2001-07-19
UA68407C2 (en) 2004-08-16
US7026281B1 (en) 2006-04-11
HUP0105094A3 (en) 2002-05-28
JP2002530432A (ja) 2002-09-17
AR022392A1 (es) 2002-09-04
NO20012489D0 (no) 2001-05-21
AU757222B2 (en) 2003-02-06
EP1133522A1 (en) 2001-09-19
CN1328570A (zh) 2001-12-26
PL349877A1 (en) 2002-09-23
CA2351665A1 (en) 2000-06-02
TR200101492T2 (tr) 2001-11-21
CO5180565A1 (es) 2002-07-30
PT1133522E (pt) 2006-11-30

Similar Documents

Publication Publication Date Title
BR9915512A (pt) Análogos antagonìsticos de gh-rh que inibem igf-i e -ii
FI974368A (fi) Kasvuhormonin vapautumista edistäviä dipeptidejä
DE69705300T2 (de) Cyclopropylalkansäurederivate
DE69836386D1 (de) Amide zur Förderung der Ausschüttung von Wachstumshormonen
ATE177757T1 (de) Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
ATE50693T1 (de) Peptidverbindungen.
DE69723728D1 (de) Totalsynthese des amino hip analogen von didemnin a
SE9101838D0 (sv) Novel peptides and their use
BRPI0413257A (pt) análogos antagonistas do hormÈnio de liberação do hormÈnio do crescimento (gh-rh)) (2003)
BR9509975A (pt) Formulação farmacêutica
ES2012720A6 (es) Procedimiento para la obtencion de sales de adicion de acido de taurina o glicina amidada.
AU579593B2 (en) Novel peptides which are active on the central nervous system and have an action on the cholinergic system
MX9702275A (es) Compuestos polipectidicos que contienen d-2 alquiltriptofano capaces de promover la liberacion de hormona del crecimiento.
ES2135398T3 (es) Compuesto y composiciones de inhibicion de la resorcion osea.
KR950703347A (ko) 이노시톨 1,4,5-트리포스페이트의 길항 방법(Method for Antagonizing Inositol 1,4,5-Triphosphate)
DE69619530T2 (de) Zyklische somatostatinanaloge mit wachstumhormon inhibierender aktivität
BR9611760A (pt) Novos antagonistas lh-rh com efeito aperfeiçoado
DE69119409T2 (de) Vasoaktive derivate des vasotocins
ATE248163T1 (de) Neuartige, pharmazeutisch aktive verbindung
FI933231A (fi) Acylaminoalkylidenhydroxibisfosfonsyror anvaendningsbara vid terapi av benledsjukdomar
ES8800271A1 (es) Un procedimiento para preparar heptapeptidos ciclicos basicos y aromaticos.
TH1762EX (th) เพพไทด์สังเคราะห์ที่แสดงฤทธิ์ปลดปล่อยฮอร์โมนช่วยการเติบโตของพิทูอิทารี
SE9501773D0 (sv) New use
MX9701526A (es) Terapia combinada para tratar la osteoporosis.

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements